Skip to main content
Pideka Group Inc. logo

Pideka Group Inc. — Investor Relations & Filings

Ticker · PDKA ISIN · CA72004D1069 CSE Manufacturing
Open in API
Filings indexed 320 across all filing types
Latest filing 2022-08-11 Proxy Solicitation & In…
Country CA Canada
Listing CSE PDKA

About Pideka Group Inc.

https://www.grupopideka.com/

Pideka Group Inc. is a multi-national operator specializing in the cultivation, production, and distribution of pharmaceutical-grade cannabis and its derivatives. The company utilizes medical-grade indoor cultivation facilities and laboratories to produce raw cannabis flower and specialized derivatives intended for scientific and pharmaceutical applications. Pideka's product offerings include pharmaceutical grade cannabinoids, decarboxylated flower, finished CBD products, and finished ingredient cannabis oil. The company focuses on providing high-quality medicinal cannabis products designed to meet or exceed international standards, serving markets through integrated operations that include cultivation, production, and distribution.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a notice regarding an upcoming Annual Special Meeting of securityholders, including details such as meeting date, record date, and voting information. It is a formal announcement related to a shareholder meeting but does not contain the meeting materials, voting results, or detailed reports. The document length is short (1090 characters), and it serves as a notification rather than the actual meeting materials or results. Therefore, it fits best under the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2022-08-11 English
Other securityholders documents - English.pdf
Regulatory Filings Classification · 95% confidence The document is a certificate issued under the Business Corporations Act certifying a change of company name. It is a formal legal or regulatory certificate, not a financial report, management announcement, or any other specific filing type related to financial performance or corporate governance changes. It does not contain financial data, management changes, or shareholder information. Given its nature as a formal certificate of name change issued by a government registrar, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2022-06-15 English
News release - English.pdf
Regulatory Filings
2022-05-31 English
News release - English.pdf
Regulatory Filings
2022-05-03 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that the company's subsidiary, Pideka SAS, has received European Good Manufacturing Practices (EU GMP) certification and is preparing for export. It includes forward-looking statements about production capacity and sales contracts but does not contain any financial statements, detailed financial performance data, or regulatory filings. There is no indication that this is an annual report, interim report, earnings release, or any other formal financial filing. The content is primarily an operational update and certification announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2022-04-28 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of a $3 million tranche of a $6 million private placement investment initiative by Ikänik Farms. It details the terms of the private placement, the use of proceeds, changes to the board of directors due to the investor's rights, and forward-looking statements about the company's operations and plans. There are no financial statements, quarterly or annual results, or detailed financial analysis included. The document focuses on financing activity and capital raising. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 7940 characters, which is sufficient for a detailed announcement but does not constitute a full financial report or earnings release.
2022-04-26 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.